iAnthus Capital Holdings, Inc. (ITHUF)
OTCMKTS · Delayed Price · Currency is USD
0.0050
-0.0001 (-1.49%)
Aug 18, 2025, 2:33 PM EDT
iAnthus Capital Holdings Market Cap
iAnthus Capital Holdings has a market cap or net worth of $48.81 million as of August 18, 2025. Its market cap has decreased by -66.86% in one year.
Market Cap
48.81M
Enterprise Value
242.33M
Revenue
155.51M
Ranking
n/a
PE Ratio
18.90
Stock Price
$0.00
Market Cap Chart
Since September 7, 2016, iAnthus Capital Holdings's market cap has increased from 13.72M to 48.81M, an increase of 255.77%. That is a compound annual growth rate of 15.25%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 15, 2025 | 48.81M | 5.17% |
| Dec 31, 2024 | 46.42M | -73.10% |
| Dec 29, 2023 | 172.55M | 4.20% |
| Dec 30, 2022 | 165.60M | 916.98% |
| Dec 31, 2021 | 16.28M | -51.67% |
| Dec 31, 2020 | 33.69M | -86.60% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Sep 7, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Nika Pharmaceuticals | 972.93M |
| Veradigm | 781.22M |
| Tian'an Technology Group | 628.15M |
| Elite Pharmaceuticals | 580.89M |
| Glass House Brands | 567.91M |
| American Oncology Network | 379.23M |
| Northwest Biotherapeutics | 363.17M |
| CytoDyn | 344.75M |